IL6 and neoplasm: Besides acting on plasma cells directly at the level of growth inhibition and induction of apoptosis [14, 15], it also reduces the production of tumor-promoting interleukins (most notably IL-6) by osteoclasts and macrophages in the bone marrow, where plasma cells home and form the tumor lesion [16].